What Analysts Are Saying About GE HealthCare Techs Stock

In the latest quarter, 9 analysts provided ratings for GE HealthCare Techs GEHC, showcasing a mix of bullish and bearish perspectives.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

Analysts have recently evaluated GE HealthCare Techs and provided 12-month price targets. The average target is $99.78, accompanied by a high estimate of $110.00 and a low estimate of $86.00. Marking an increase of 13.88%, the current average surpasses the previous average price target of $87.62.

Exploring Analyst Ratings: An In-Depth Overview

A comprehensive examination of how financial experts perceive GE HealthCare Techs is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to GE HealthCare Techs. This information provides a snapshot of how analysts perceive the current state of the company.
• Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of GE HealthCare Techs compared to the broader market.
• Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of GE HealthCare Techs's stock. This examination reveals shifts in analysts' expectations over time.

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of GE HealthCare Techs's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.

Stay up to date on GE HealthCare Techs analyst ratings.

All You Need to Know About GE HealthCare Techs

GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.

Understanding the Numbers: GE HealthCare Techs's Finances

Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.

Revenue Growth: GE HealthCare Techs displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 5.43%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.

Net Margin: GE HealthCare Techs's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 7.74%, the company may face hurdles in effective cost management.

Return on Equity (ROE): GE HealthCare Techs's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.65% ROE, the company effectively utilizes shareholder equity capital.

Return on Assets (ROA): GE HealthCare Techs's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.24%, the company may face hurdles in achieving optimal financial performance.

Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.38, caution is advised due to increased financial risk.

What Are Analyst Ratings?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

This article was generated by Benzinga's automated content engine and reviewed by an editor.